Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Oakley Capital leads race for G3 in £250m corporate intelligence play
Oakley Capital leads race for G3 in £250m corporate intelligence play Private equity interest is intensifying around G3, the corporate intelligence firm chaired by ex-MI6 chief Sir John Sawers, with Oakley Capital reportedly leading the pack in a potential deal...
Restructuring wave draws hedge fund interest in French PE-backed firms
Restructuring wave draws hedge fund interest in French PE-backed firms Hedge funds are circling a growing number of distressed companies in France, many of which are backed by private equity, as rising debt burdens and economic headwinds trigger a wave of...
Inflexion exits control of Medik8 as L’Oréal deepens premium skincare push
Inflexion exits control of Medik8 as L’Oréal deepens premium skincare push L’Oréal has agreed to acquire a majority stake in Medik8, the British premium skincare brand, in a move that strengthens its Luxe Division’s portfolio and underscores continued private equity...